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Abstract— The first synthesis of an enantiomerically pure C2 symmetric benzothiadiazole 2-oxide is described along with the first 
synthesis of a enantiomerically thiadiazol-3-one 1-oxide and a thiatriaza-indene 3-Oxide system both chiral at the Sulfur atom. Excellent 
levels of diasteroselectivity were observed in the SO installation step, i.e. reaction of the prerequisite bis-amines with thionyl chloride at 
ambient temperature. © 2014 Elsevier Science. All rights reserved 
1.0 Introduction 
There are a wide number of reports utilizing a 1,3-
dinitrogen skeleton as a basis for catalyst/ligand design; for 
example, N-heterocyclic carbenes 1,1 phosphoramides 2,2 
and thioureas 3 (Figure 1).3 Indeed 1,3-amines and imines 
have themselves been reported as ligands and catalysts. 
However, there are very few reports regarding the synthesis 
of structurally related thiadiazolidines 4 or thiadiazolidine 
oxides 5. The majority of reports regarding thiadiazolidine-
1,1-dioxides 6 relate to their pharmacological properties,4 
the zwitterion 7 has been used in a Mitsunobu-type 
reaction5 and 8 has been employed as a chiral auxiliary in 
reactions which have traditionally used the Oppolzer 
sultam.6 Thiadiazolidine 1,1-dioxides have also been 
reported as useful polar aprotic solvents7 and as key 
intermediates for the synthesis of constrained peptides.8 We 
were particularly attracted to the thiadiazolidine oxides as 
we postulated that they may be interesting and useful 
ligands for phosphine free metal-catalysed reactions. 
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Figure 1. Various 1,3-dintrogen containing compounds 
To this end we were the first to report the highly active 
thiadiazolidine 1-oxide 9 catalyst system in the Mizoroki–
Heck reaction (Scheme 1).9 Excellent yields of stilbenes 
derived from aryl iodides and bromides have been achieved 
using as little as 0.00002 mol% catalyst. The 
ligand/palladium system can be stored as a stock solution 
open to air at room temperature with no observable loss of 
activity for a period of several months.  
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Scheme 1. Application of the thiadiazolidine 1-oxide system for the 
Mizoroki-Heck reaction. 
The synthesis of the mesityl-derived thiadiazolidine 1-
oxide ligand 9 was easily achieved in two steps; mesityl 
amine and glyoxal were reacted neat, and upon formation 
of the bright yellow bis-imine, sodium borohydride/ethanol 
was added to furnish the bis-amine 10 in excellent yield 
(Scheme 2). Treatment of a solution of 10 in 
diethylether/triethylamine with thionyl chloride afforded 
the thiadiazolidine oxide 9 in good yield. 
N
S
N
O
NH2 i) Glyoxal, neat 10 min
ii) NaBH4, EtOH,
12 h, 93%
NH HN
Thionyl Chloride
Et3N, Et2O, 0ºC
12 h 83%
10
9  
Scheme 2. Synthesis of the thiadiazolidine 1-oxide 9 
Our strategy for the development of highly enantioselective 
catalysis revolves around the fact that if the substituents 
attached at the nitrogen atoms of a thiadiazolidine 1-oxide 
system are non-equivalent then the sulfur atom will be 
chiral. This means that the controlling chiral element for 
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asymmetric catalysis will be directly attached to the metal 
atom and hence will be closer to the site of the reaction. 
This should then impart high levels of enantiomeric excess. 
The corresponding phosphine systems have been shown to 
impart high levels of enantiomeric excess, prominent 
examples of chiral phosphorus ligand systems are the C2-
symmetric non-functionalized bisphospholane ligands 
DuPHOS, and BPE and the oxyfunctionalized 
bisphospholanes RoPHOS and BASPHOS, as well as 
several monophospholanes being part of mono- or 
bidentate ligands. However, the discovery of new, efficient 
P-chiral bisphosphanes has been slow, partly because of the 
difficulties in ligand synthesis, and their synthetic routes 
are characterized by several disadvantages, e.g. poor air 
stability, low variability, limited tolerance of functional 
groups and serious problems during up scaling due to 
extreme or hazardous reaction conditions. Hence, we 
believe our systems will add significant value to this highly 
topical area. 
To the best of our knowledge, the synthesis and application 
of the enantiomerically pure C2 symmetric 
benzothiadiazoline 1-oxide, and the thiadiazol-3-one 1-
oxide and thiatriazoline 1-oxide systems chiral at sulfur 
have not been reported. This communication details our 
efforts to synthesize the first such examples. 
2.0 Results and Discussion 
For simplicity we initially chose to prepare a C2 symmetric 
ligand. Diver has reported the use of C2 symmetric 
carbenes based on a benzimidazole structure,10 and this 
prompts us to describe our own results in this area. Such a 
design of ligand is attractive because both of the 
enantiomers are, in principle, available, and because the 
ligands can be readily accessed through a short synthetic 
sequence; for example, the 1,2-bis-α-methylbenzylaniline 
11 was easily prepared as shown in Scheme 3. The use of 
two sequential Buchwald-Hartwig couplings nevertheless 
proved frustrating as the second reaction consistently gave 
a lower yield than expected: reaction of the amine with 
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Scheme 3. Synthesis of the 1,2-bis-α-methylbenzylaniline 11.11 
1,2-dibromobenzene gave the monosubstituted product in 
an excellent 87% yield, but attempts to introduce the 
second amine gave the desired product in no more than a 
respectable 60% yield in our hands. 
Treatment of 1,2-bis-α-methylbenzylaniline 11 with thionyl 
chloride in diethylether/triethylamine afforded the C2 
symmetric benzothiadiazole 2-oxide 12 in a disappointing 
30% yield (Scheme 4). 
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Scheme 4. Synthesis of the benzothiadiazole 2-oxide 12. 11 
We have also attempted the synthesis of a related C2 
symmetric system outlined in Scheme 5.12 Unfortunately 
cyclization to incorporate the SO moiety proved 
unsuccessful perhaps due to the steric crowding of the two 
nitrogen atoms. 
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Scheme 5. Attempted synthesis of a cyclohexyldiamine derivative. 11 
In order to develop a synthesis of a system chiral at sulfur 
we chose to prepare a thiatriazoline 1-oxide as the synthesis 
of enantiomerically pure unsymmetrical 1,3-diamines has 
been reported to be non-trivial.13 Leeper,14 Enders,15 
Rovis16 and others17 have shown that the NHC triazolium 
systems are capable of delivering high enantioselectivities 
in a variety of transformations, hence we chose a similar 
route to prepare the thiatriaza-indene 3-oxide 13. 
Thiatriaza-indene 3-oxide 13 was synthesized using the 
following protocol (Scheme 6): coupling of 
ethylchloroacetate and phenylglycinol under basic 
conditions afforded the amide 14 in 61% yield. The amide 
moiety was then converted to the imino ether 15 using 
trimethyloxonium tetraflouroborate Addition of 
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Scheme 6. Synthesis of the thiatriaza-indene 3-oxide 13. 11     Figure 2. X-ray crystal structure of 13. 
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phenylhydrazine hydrochloride afforded the a bis-amine 
precursor 16 which was suitable for treatment with thionyl 
chloride under the standard conditions to afford the 
intended target molecule 13 as a single diastereoisomer (as 
determined by 1H and 13C NMR spectroscopy) in 71% 
yield. Compound 13 was found to be crystalline and the X-
ray crystal structure18 is shown in Figure 2. It is interesting 
to note that the oxygen at sulfur is on the opposite face to 
that of the phenyl group in the morpholine ring system. 
We next turned our attention to preparing a thiadiazol-3-
one 1-oxide and this was achieved initially by the 
esterification of phenylalanine 17, followed by conversion 
of the ester moiety to the secondary amide 18 using 
methylamine. The primary amine was then protected with a 
p-methoxybenzyl group and subsequent treatment of the 
bis-amine 19 with thionyl chloride resulted in the final 
product 20 in four simple steps (Scheme 6). Unfortunately 
compound 20 was an oil and we have as yet been 
unsuccessful in determining the absolute stereochemistry at 
sulfur. By 1H and 13C NMR spectroscopy compound 20 
appears to be a single diastereoisomer. 
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Scheme 7. Synthesis of the thiadiazol-3-one 1-oxide 20. 11 
 
3.0 Conclusion 
We have successfully synthesized the first example of a 
enantiomerically pure C2 symmetric benzothiadiazole 2-
oxide. We have also prepared the first thiatriaza-indene 3-
oxide and thiadiazol-3-one 1-oxide systems chiral at the 
sulfur atom in high diastereoselectivity. We shall now 
endeavor to apply these and related systems in asymmetric 
catalysis. 
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